A team led by Dr Nefussy at the University of Tel-Aviv trialled the use of a drug called Granulocyte-colony stimulating factor (G-CSF) for treatment of MND. G-CSF is used to mobilise a sub-population of white blood cells from the bone marrow to the blood.
G-CSF was found to be effective at mobilising cells into the blood. Although there was a trend of slowing disease progression following two G-CSF treatments by the end of the study the analysis showed there was no statistically significant benefit of the drug after six months.
Source: International MND research update – June 2009, Dr Justin Yerbury for MNDRIA